FGF21 and adipose lipolysis in alcoholic fatty liver
FGF21 and adipose lipolysis in alcoholic fatty liver
批准号:
8702281
负责人:
WENKE FENG
金额:
$21.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2016-06-30
关键词:
Adipose tissueAlcohol consumptionAlcoholic Fatty LiverAlcoholic Liver DiseasesAlcoholsAnimal ModelAttenuatedBody fatCaloriesCapsid ProteinsCatecholaminesChronicCirrhosisCyclic AMPDataDeuteriumDevelopmentEndocrineEpidemiologic StudiesEthanolExperimental Animal ModelExposure toFatty LiverFatty acid glycerol estersFibroblast Growth FactorFibrosisGoalsHepaticHepatitisHepatocyteHomeostasisHormonesHyperlipidemiaIncubatedInsulinKnock-outKnockout MiceLabelLipidsLipolysisLiverLiver diseasesMediatingMediator of activation proteinMetabolicMolecularNicotinic AcidsNonesterified Fatty AcidsPathway interactionsPatientsPhosphorylationPlasmaPlayPrimary carcinoma of the liver cellsRecombinant Fibroblast Growth FactorRegulationReportingResistanceRodentRoleSerumSignal TransductionTestingTherapeuticTransgenic MiceTransgenic OrganismsTriglyceridesWild Type Mousealcohol exposurealcohol responseautocrinebasedeprivationfatty acid transportfeedingfibroblast growth factor 21improvedlipid biosynthesislipid metabolismmeetingsmembermouse modeloverexpressionoxidationperilipinproblem drinkerpublic health relevancereceptorresponsesterol esteraseuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Alcoholic fatty liver is considered as the earliest pathological alteration of progression in alcoholic liver disease (ALD) from hepatic steatosis to hepatitis, fibrosis, cirrhosis and even hepatocellular carcinoma. Hepatic reverse transport of free
fatty acids (FFAs) derived from adipose hyperlipolysis resulting from alcohol ingestion plays a critical role in fatty liver formation. However, the mechanisms by which alcohol regulates adipose tissue lipolysis are unclear. Recently, fibroblast growth factor 21 (FGF21) has emerged as a hepatic regulatory factor that acts on multiple targets, including the liver itself in an autocrine fashion, and importantly on white adipose tissue to regulate lipid homeostasis. We have found that FGF21 plays a critical role in alcohol-induced adipose lipolysis and in hepatic fat accumulation in animal models of ALD, and circulating FGF21 levels are significantly increased in patients with ALD and in experimental animal models. However, how FGF21 regulates adipose tissue lipolysis during alcohol exposure is not known. The aims of this project are to investigate the role of FGF21 in adipose tissue lipolysis in response to alcohol exposure to improve our understanding of the molecular mechanisms in the regulation and action of this hormone in ALD, and to assess the therapeutic potential in alcohol-induced fatty liver formation. To achieve this goal, we will carry out the following specific aims. In aim 1 we will determine whether FGF21 plays a stimulatory role in adipose tissue lipolysis and the underlying mechanisms associated with hormone sensitive lipase and perilipin pathway during alcohol exposure using FGF21 knockout and transgenic overexpression mouse models. In the second aim, we will test our hypothesis that adipose tissue specific disruption of FGF21 decreases FFA release and hepatic uptake and attenuates alcohol-induced fatty liver formation using adipose selective ¿-klotho knockout mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cannabidiol as a treatment for alcoholic liver disease
-
批准号:10753729
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2023
-
负责人:WENKE FENG
-
依托单位:
Intestine FXR activation by LGG-derived nanoparticles in alcohol-associated liver disease
-
批准号:10531712
-
项目类别:
-
资助金额:$53.2万
-
财政年份:2022
-
负责人:WENKE FENG
-
依托单位:
Intestine FXR activation by LGG-derived nanoparticles in alcohol-associated liver disease
-
批准号:10794805
-
项目类别:
-
资助金额:$51.98万
-
财政年份:2022
-
负责人:WENKE FENG
-
依托单位:
Probiotic-derived nano-particles in alcoholic liver disease
-
批准号:10056416
-
项目类别:
-
资助金额:$8.07万
-
财政年份:2016
-
负责人:WENKE FENG
-
依托单位:
Probiotic-derived nano-particles in alcoholic liver disease
-
批准号:10625858
-
项目类别:
-
资助金额:$20.7万
-
财政年份:2016
-
负责人:WENKE FENG
-
依托单位:
Mechanisms of Probiotics in Alcoholic Liver Disease
-
批准号:9325388
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2015
-
负责人:WENKE FENG
-
依托单位:
Mechanisms of Probiotics in Alcoholic Liver Disease
-
批准号:10457385
-
项目类别:
-
资助金额:$21.73万
-
财政年份:2015
-
负责人:WENKE FENG
-
依托单位:
Mechanisms of Probiotics in Alcoholic Liver Disease
-
批准号:10250531
-
项目类别:
-
资助金额:$43.54万
-
财政年份:2015
-
负责人:WENKE FENG
-
依托单位:
Mechanisms of Probiotics in Alcoholic Liver Disease
-
批准号:9766984
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2015
-
负责人:WENKE FENG
-
依托单位:
Mechanisms of Probiotics in Alcoholic Liver Disease
-
批准号:10794806
-
项目类别:
-
资助金额:$42.7万
-
财政年份:2015
-
负责人:WENKE FENG
-
依托单位:
Probiotics and HIF signaling in Alcoholic Liver Disease
-
批准号:8597993
-
项目类别:
-
资助金额:$16.03万
-
财政年份:2012
-
负责人:WENKE FENG
-
依托单位:
Probiotics and HIF signaling in Alcoholic Liver Disease
-
批准号:8385354
-
项目类别:
-
资助金额:$21.56万
-
财政年份:2012
-
负责人:WENKE FENG
-
依托单位:
Mechanisms of Probiotics in Alcoholic Liver Disease
-
批准号:9293343
-
项目类别:
-
资助金额:$18.84万
-
财政年份:--
-
负责人:WENKE FENG
-
依托单位:
海外基金